- Company
- A study on Korean patients by Nebilet are released
- by Nov 11, 2020 06:08am
- Menarini Korea (CEO Park Hye-young) presented the results of a BENEFIT subgroup study of Nebilet(Nebivolol, β-blocker) at the 53rd Fall International Conference on the Korean Society of Hypertension (Hypertension Seoul 2020). It was revealed on the 9th. The conference, which was held for two days from the 6th to the 7th, was conducted in
- Company
- Viatris separated from Pfizer, officially launched next week
- by Eo, Yun-Ho Nov 10, 2020 05:55pm
- Pfizer's patent expiration division and Mylan’s merger Independent corporation, Viatris, will be officially launched next Monday (16th). According to related industries, in accordance with global measures, Viatris, a Korean subsidiary (currently Pfizer Upjohn Korea), will also be administratively separated from Pfizer and start operating
- Company
- Roche to expand rare disease treatment market presence
- by Eo, Yun-Ho Nov 10, 2020 06:06am
- An anticancer drug powerhouse Roche is consolidating its presence in the rare disease treatment area. In just a week, Roche Korea has won the South Korean health authority’s approval on two new drugs, and it is also bringing another new drug to the Korean market soon. The three new drugs are respectively indicated to treat patients
- Company
- Daewoong,enters phase III of indications for Enavogliflozin
- by Nov 10, 2020 06:05am
- Daewoong (CEO Seung-ho Jeon) announced on the 30th of last month that it had received approval for a phase III clinical trial from the MFDS for the combination therapy of Enavogliflozin, Metformin, and DPP-4 inhibitor, which are being developed as a new drug for diabetes treatment. Enavogliflozin is a new drug for the treatment of SGLT-2 d
- Company
- Covered drugs decreased due to generic drug price system
- by Chon, Seung-Hyun Nov 9, 2020 06:18am
- The soaring number of medicines covered by health insurance showed a sharp decline. As the number of new generic licenses decreased due to the implementation of the new drug price system, the number of covered drugs decreased in 11 months. According to the HIRA on the 8th, as of November 1, the total number of drugs on the health insuranc
- Company
- Generics for Lyrica, expanded by 60% in 3 years
- by Kim, Jin-Gu Nov 9, 2020 06:18am
- The market for Pregabalin, a pain treatment drug for peripheral neuropathy, has expanded rapidly over the past three years. The amount of outpatient prescriptions from &8361;19.8 billion in the third quarter of 2017 increased 61% to &8361;32 billion in three years. It is an analysis that the growth of generics after the expiration of th
- Company
- Rx performance is poor due to spin-off of Organon
- by Kim, Jin-Gu Nov 9, 2020 06:17am
- MSD Korea's spin-off of Organon has come for three months. However, sales of most Organon items, such as Singulair, Vitorin, and Cozaar, are sluggish in the domestic outpatient prescription market. In contrast, Sales of Januvia by MSD increased by nearly 10%. According to UBIST on the 4th, MSD's outpatient prescriptions in the third quarte
- Company
- Servier Korea has appointed Melanie Loresry as new CEO
- by Eo, Yun-Ho Nov 6, 2020 06:25am
- Servier Korea appoints a new head. According to related industries, Servier Korea appointed Melanie Loresry (43) as new CEO, on the 1st of last month. Colette Rouches, who had previously led Servier Korea, moved to a Taiwanese subsidiary. This allowed Servier to continue the female CEO system. French CEO Melanie Loresry has been in the
- Company
- MSD Korea’s trade union protests against organon's spinoff
- by Nov 6, 2020 06:25am
- The MSD Korea’s trade union began disputes on the 3rd due to the breakdown of the second round of mediation by the National Labor Relations Commission on the 2nd. On the 3rd, the union hung a picket and banner on the MSD Korea office building in Seoul Square, urging against the spin-off of Organon and urged cooperation in signing a colle
- Company
- Menarini Korea labor union in pursuit of stable job security
- by An, Kyung-Jin Nov 6, 2020 06:25am
- On Nov. 4, Korea Democratic Pharmaceutical Union reported Menarini Korea has recently established a labor union and joined the Democratic Union as a new chapter. Sources confirm the company union has completed the union registration on Oct. 28 and started their official activities from then on. Menarini Korea is a multinational company t
